📖 Complete Guide✅ Updated 2026🔬 Evidence-Based

Vyleesi (Bremelanotide) Guide for HSDD 2026

Complete Guide & Evidence (2026)

The complete guide to Vyleesi (Bremelanotide), the FDA-approved peptide for Hypoactive Sexual Desire Disorder in women.

Last reviewed: March 2026

FDA-Approved Peptide for HSDD

Vyleesi (generic name Bremelanotide, originally PT-141) is an FDA-approved injectable peptide designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.

What Is Vyleesi (Bremelanotide) Guide?

Vyleesi (generic name Bremelanotide, originally PT-141) is an FDA-approved injectable peptide designed to treat Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.

Unlike PDE5 inhibitors (Viagra) which alter blood flow, Vyleesi works centrally in the brain by binding to melanocortin receptors, lighting up neural pathways associated with sexual arousal and desire.

Key Biohacking Mechanics

Non-selective agonist of melanocortin receptors (MC1R and MC4R)

MC4R binding directly modulates sexual responses and arousal

Operates on the desire phase — restoring libido, not just mechanics

Melanocortin pathway stimulation causes downstream dopamine release

Dopamine is the primary neurotransmitter for anticipation, reward, and desire

Effects build over 45-60 minutes post-injection

Dosing Protocol

SubQ injection into abdomen or thigh.

At least 45 minutes before anticipated activity.

No more than ONE dose per 24 hours, max 8 per month.

Note: Severe nausea occurs in ~40% of patients. Antiemetic medication or slow titration is often required. Do NOT exceed dose limits — it severely spikes blood pressure.

Side Effects & Safety

🔬

Common Effects

Nausea (40% of patients — most common). Facial flushing and warmth. Headache. Injection site reactions

🔬

Important Warnings

Focal hyperpigmentation if used more than 8x/month. Blood pressure elevation at higher doses. Not for use in men (off-label PT-141 is different). Skin darkening of gums, face, or breasts possible

Vital Protocol FAQs

🔬

Why does Vyleesi cause such bad nausea?

Because it activates melanocortin receptors everywhere, it triggers nausea centers in the brain. For many, nausea fades after a few uses, but for some it requires discontinuation.

🔬

Does Vyleesi work for men?

While exclusively FDA-approved for premenopausal women, the generic peptide (Bremelanotide/PT-141) is widely used in men for inducing spontaneous erections by bypassing nitric-oxide pathways.

✨

Will it darken my skin?

Yes, focal hyperpigmentation was observed in trials if used more than 8 times a month, due to MC1R (tanning receptor) activation.

Guide FAQs